Method for detecting glucagon-like peptide-1 antagonists and agonists
US5846747A · kind A · utility
48Cited by
1References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 5, 1997 |
| Grant date | Dec 8, 1998 |
| Priority date | — |
| Expiry date | Jun 5, 2017 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/72
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to a recombinant glucagon-like peptide-1 (GLP-1) receptor, to a DNA construct which comprises a DNA sequence encoding a GLP-1 receptor, to methods of screening for antagonists of GLP-1 activity, and to the use of the GLP-1 receptor for screening for antagonists of GLP-1 activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.